BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Cell Therapeutics, Inc. 

201 Elliott Avenue West, Suite 400

Seattle  Washington  98119  U.S.A.
Phone: 206-282-7100 Fax: 206-284-6206


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Cell Therapeutics, Inc. (CTIC) Announces Change Of Name To CTI BioPharma Corp. 5/30/2014 8:51:38 AM
Cell Therapeutics, Inc. (CTIC) To Present At The Jefferies and Co. 2014 Global Healthcare Conference 5/29/2014 6:36:16 AM
Cell Therapeutics, Inc. (CTIC) Reports First Quarter 2014 Financial Results 4/30/2014 7:06:11 AM
Cell Therapeutics, Inc. (CTIC) PIXUVRI® Launched In UK For Adult Patients With Multiply Relapsed Or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma 4/29/2014 10:15:38 AM
Cell Therapeutics, Inc. (CTIC) To Report First Quarter 2014 Financial Results On April 29, 2014 4/22/2014 6:04:43 AM
Cell Therapeutics, Inc. (CTIC) To Present At The 26th Annual ROTH Conference 3/5/2014 7:09:49 AM
Cell Therapeutics, Inc. (CTIC) Reports Fourth Quarter And Full Year 2013 Financial Results 3/5/2014 6:51:32 AM
Cell Therapeutics, Inc. (CTIC) Opens Enrollment For PERSIST-2 Phase 3 Trial Of Pacritinib For Patients With Myelofibrosis Who Have Low Platelet Counts 3/3/2014 10:24:16 AM
Cell Therapeutics, Inc. (CTIC) Release: National Institute for Clinical Excellence (NICE) Publishes Final Guidance On PIXUVRI® (pixantrone) 2/27/2014 9:51:56 AM
Cell Therapeutics, Inc. (CTIC) To Report Fourth Quarter And Full Year 2013 Financial Results On March 4, 2014 2/25/2014 6:12:43 AM
12345678910...